March 14-17, 2022
San Diego Convention CenterSan Diego, CaliforniaTheodore Peters, Ph.D.Senior Scientist, Bioprocess Development at Seagen
Profile
Ted has over five years of experience in the biopharmaceutical industry developing clonal CHO cell lines for the production of therapeutic antibodies. In his current role, Ted is interested in elucidating sources of genetic drift in CHO cells in an effort to identify cell lines that can maintain stable expression. Ted received his Ph.D. at the University of Colorado - Health Sciences Center and continued his training at the Buck Institute for Research on Aging as a postdoctoral scholar.
Agenda Sessions
Investigation of Gene Expression Patterns in Stable and Unstable Clonally-Derived CHO Cell Lines
, 1:40pmView SessionPanel: Methods to Increase Stability of Cell Lines
, 2:05pmView Session